BLEV.F Stock Overview
Operates as a medical cannabis company in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Beleave Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0024 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 33 Year Change | -99.67% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BLEV.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 2.2% |
| 1Y | 0% | 9.9% | 31.6% |
Return vs Industry: BLEV.F underperformed the US Pharmaceuticals industry which returned 9.9% over the past year.
Return vs Market: BLEV.F underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| BLEV.F volatility | |
|---|---|
| BLEV.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BLEV.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine BLEV.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Bill Panagiotakopoulos | beleave.com |
Beleave Inc. operates as a medical cannabis company in Canada. The company cultivates and sells medical and recreational cannabis products. It also operates a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.
Beleave Inc. Fundamentals Summary
| BLEV.F fundamental statistics | |
|---|---|
| Market cap | US$553.00 |
| Earnings (TTM) | -US$11.80m |
| Revenue (TTM) | US$2.07m |
0.0x
P/S Ratio0.0x
P/E RatioIs BLEV.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLEV.F income statement (TTM) | |
|---|---|
| Revenue | CA$2.90m |
| Cost of Revenue | CA$6.71m |
| Gross Profit | -CA$3.82m |
| Other Expenses | CA$12.68m |
| Earnings | -CA$16.49m |
Last Reported Earnings
Dec 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BLEV.F perform over the long term?
See historical performance and comparison